Anika Therapeutics, Inc.: net_income

Value{"amount": 38319479, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Period2014-01-01 – 2014-12-31
Statussuperseded
EntityAnika Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001171843-15-001395
Retrieved: 2026-08-19T09:02:47.738007+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000898437/net-income/2014-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/81ae8539-72d7-4129-8756-13da2db7acab

History